Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin
出版年份 2015 全文链接
标题
Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin
作者
关键词
Triple-negative breast cancer (TNBC), Breast cancer stem cells (BCSCs), Histone deacetylase (HDAC) inhibitor, LBH589 (panobinostat), Salinomycin
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 151, Issue 2, Pages 281-294
出版商
Springer Nature
发表日期
2015-04-22
DOI
10.1007/s10549-015-3376-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators
- (2014) Lyndsay V. Rhodes et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
- (2014) Paola Marcato et al. Molecular Oncology
- Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
- (2014) Prithviraj Bose et al. PHARMACOLOGY & THERAPEUTICS
- Histone deacetylase inhibitors
- (2013) Marije Slingerland et al. ANTI-CANCER DRUGS
- Salinomycin induces apoptosis and senescence in breast cancer: Upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation
- (2013) Yusra Al Dhaheri et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers
- (2013) Anita Bane et al. BREAST CANCER RESEARCH AND TREATMENT
- HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells
- (2013) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
- (2013) E. Charafe-Jauffret et al. CANCER RESEARCH
- FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer
- (2013) B. G. Hollier et al. CANCER RESEARCH
- The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
- (2013) M. A. Salvador et al. CLINICAL CANCER RESEARCH
- Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells
- (2012) Che-Hsin Lee et al. BIOCHIMIE
- Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer
- (2012) Julia Y. S. Tsang et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
- (2012) Makoto Kubo et al. BREAST CANCER RESEARCH AND TREATMENT
- Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
- (2012) N. P. A. Devika Gunasinghe et al. CANCER AND METASTASIS REVIEWS
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Breast Cancer Stem Cells: A Novel Therapeutic Target
- (2012) Sudeshna Gangopadhyay et al. Clinical Breast Cancer
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
- (2012) R. Rao et al. MOLECULAR CANCER THERAPEUTICS
- Histone Deacetylase Inhibitors Stimulate Dedifferentiation of Human Breast Cancer Cells Through WNT/β-Catenin Signaling
- (2012) Bisrat G. Debeb et al. STEM CELLS
- Salinomycin - A New Cancer Drug Candidate
- (2011) Adam Huczynski Chemical Biology & Drug Design
- The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
- (2011) Taj D. King et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal
- (2011) X Fang et al. ONCOGENE
- Management of triple negative breast cancer
- (2010) Catherine Oakman et al. BREAST
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression
- (2010) S. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
- (2010) Julia M. Wagner et al. Clinical Epigenetics
- Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
- (2009) Erika Resetkova et al. BREAST CANCER RESEARCH AND TREATMENT
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
- Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance
- (2009) Rosaria Gangemi et al. CURRENT MEDICINAL CHEMISTRY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- BRCA1 regulates human mammary stem/progenitor cell fate
- (2008) S. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now